Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.
Although many chemotherapeutic strategies against cancer have been developed, pancreatic cancer is one of the most aggressive and intractable types of malignancies. Therefore, new strategies and anti-cancer agents are necessary to treat this disease. Metformin is a widely used drug for type-2 diabet...
Asıl Yazarlar: | Ryoichi Tanaka, Mitsuhiro Tomosugi, Mano Horinaka, Yoshihiro Sowa, Toshiyuki Sakai |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Public Library of Science (PLoS)
2015-01-01
|
Seri Bilgileri: | PLoS ONE |
Online Erişim: | http://europepmc.org/articles/PMC4425682?pdf=render |
Benzer Materyaller
-
Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression
Yazar:: Seok Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01) -
Involvement of Up-Regulation of DR5 Expression and Down-Regulation of c-FLIP in Niclosamide-Mediated TRAIL Sensitization in Human Renal Carcinoma Caki Cells
Yazar:: Jeong Mi Yun, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01) -
Smenospongine, a Sesquiterpene Aminoquinone from a Marine Sponge, Induces G1 Arrest or Apoptosis in Different Leukemia Cells
Yazar:: Motomasa Kobayashi, ve diğerleri
Baskı/Yayın Bilgisi: (2008-08-01) -
Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells.
Yazar:: Masami Ichikawa, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01) -
The dual RAF/MEK inhibitor CH5126766/RO5126766 may be a potential therapy for RAS-mutated tumor cells.
Yazar:: Makoto Wada, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)